Manuel Joaquín Romero-López , Hilda Jiménez-Wences , Merlin Itsel Cruz-De La Rosa , Judit Alarcón-Millán , Miguel Ángel Mendoza-Catalán , Elizabeth Ortiz-Sánchez , José Manuel Tinajero-Rodríguez , Daniel Hernández-Sotelo , Gladys Wendy Valente-Niño , Dinorah Nashely Martínez-Carrillo , Gloria Fernández-Tilapa
{"title":"miR-218-5p, miR-124-3p and miR-23b-3p act synergistically to modulate the expression of NACC1, proliferation, and apoptosis in C-33A and CaSki cells","authors":"Manuel Joaquín Romero-López , Hilda Jiménez-Wences , Merlin Itsel Cruz-De La Rosa , Judit Alarcón-Millán , Miguel Ángel Mendoza-Catalán , Elizabeth Ortiz-Sánchez , José Manuel Tinajero-Rodríguez , Daniel Hernández-Sotelo , Gladys Wendy Valente-Niño , Dinorah Nashely Martínez-Carrillo , Gloria Fernández-Tilapa","doi":"10.1016/j.ncrna.2024.02.016","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>In cervical cancer (CC), miR-218-5p, -124-3p, and −23b-3p act as tumor suppressors. These miRNAs have specific and common target genes that modulate apoptosis, proliferation, invasion, and migration; biological processes involved in cancer.</p></div><div><h3>Methods</h3><p>miR-218-5p, -124-3p, and −23b-3p mimics were transfected into C-33A and CaSki cells, and RT-qPCR was used to quantify the level of each miRNA and <em>NACC1</em>. Proliferation was assessed by BrdU and apoptosis by Annexin V/PI. In the TCGA and The Human Protein Atlas databases, the level of <em>NACC1</em> mRNA and protein (putative target of the three miRNAs) was analyzed in CC and normal tissue. The relationship of NACC1 with the overall survival in CC was analyzed in GEPIA2. <em>NACC1</em> mRNA and protein levels were higher in CC tissues compared with cervical tissue without injury.</p></div><div><h3>Results</h3><p>An increased expression of NACC1 was associated with lower overall survival in CC patients. The levels of miR-218-5p, -124-3p, and −23b-3p were lower, and NACC1 was higher in C-33A and CaSki cells compared to HaCaT cells. The increase of miR-218-5p, -124-3p, and −23b-3p induced a significant decrease in <em>NACC1</em> mRNA. The transfection of the three miRNAs together caused more drastic changes in the level of <em>NACC1</em>, in the proliferation, and in the apoptosis with respect to the individual transfections of each miRNA.</p></div><div><h3>Conclusion</h3><p>The results indicate that miR-218-5p, -124-3p, and −23b-3p act synergistically to decrease NACC1 expression and proliferation while promoting apoptosis in C-33A and CaSki cells. The levels of <em>NACC1</em>, miR-218-5p, -124-3p, and −23b-3p may be a potential prognostic indicator in CC.</p></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"9 3","pages":"Pages 720-731"},"PeriodicalIF":5.9000,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468054024000374/pdfft?md5=68c7573af64739830acc91c0fb426058&pid=1-s2.0-S2468054024000374-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Non-coding RNA Research","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468054024000374","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
In cervical cancer (CC), miR-218-5p, -124-3p, and −23b-3p act as tumor suppressors. These miRNAs have specific and common target genes that modulate apoptosis, proliferation, invasion, and migration; biological processes involved in cancer.
Methods
miR-218-5p, -124-3p, and −23b-3p mimics were transfected into C-33A and CaSki cells, and RT-qPCR was used to quantify the level of each miRNA and NACC1. Proliferation was assessed by BrdU and apoptosis by Annexin V/PI. In the TCGA and The Human Protein Atlas databases, the level of NACC1 mRNA and protein (putative target of the three miRNAs) was analyzed in CC and normal tissue. The relationship of NACC1 with the overall survival in CC was analyzed in GEPIA2. NACC1 mRNA and protein levels were higher in CC tissues compared with cervical tissue without injury.
Results
An increased expression of NACC1 was associated with lower overall survival in CC patients. The levels of miR-218-5p, -124-3p, and −23b-3p were lower, and NACC1 was higher in C-33A and CaSki cells compared to HaCaT cells. The increase of miR-218-5p, -124-3p, and −23b-3p induced a significant decrease in NACC1 mRNA. The transfection of the three miRNAs together caused more drastic changes in the level of NACC1, in the proliferation, and in the apoptosis with respect to the individual transfections of each miRNA.
Conclusion
The results indicate that miR-218-5p, -124-3p, and −23b-3p act synergistically to decrease NACC1 expression and proliferation while promoting apoptosis in C-33A and CaSki cells. The levels of NACC1, miR-218-5p, -124-3p, and −23b-3p may be a potential prognostic indicator in CC.
期刊介绍:
Non-coding RNA Research aims to publish high quality research and review articles on the mechanistic role of non-coding RNAs in all human diseases. This interdisciplinary journal will welcome research dealing with all aspects of non-coding RNAs-their biogenesis, regulation and role in disease progression. The focus of this journal will be to publish translational studies as well as well-designed basic studies with translational and clinical implications. The non-coding RNAs of particular interest will be microRNAs (miRNAs), small interfering RNAs (siRNAs), small nucleolar RNAs (snoRNAs), U-RNAs/small nuclear RNAs (snRNAs), exosomal/extracellular RNAs (exRNAs), Piwi-interacting RNAs (piRNAs) and long non-coding RNAs. Topics of interest will include, but not limited to: -Regulation of non-coding RNAs -Targets and regulatory functions of non-coding RNAs -Epigenetics and non-coding RNAs -Biological functions of non-coding RNAs -Non-coding RNAs as biomarkers -Non-coding RNA-based therapeutics -Prognostic value of non-coding RNAs -Pharmacological studies involving non-coding RNAs -Population based and epidemiological studies -Gene expression / proteomics / computational / pathway analysis-based studies on non-coding RNAs with functional validation -Novel strategies to manipulate non-coding RNAs expression and function -Clinical studies on evaluation of non-coding RNAs The journal will strive to disseminate cutting edge research, showcasing the ever-evolving importance of non-coding RNAs in modern day research and medicine.